Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lex Machina is a legal analytics company that provides data-driven insights into litigation for law firms and corporations. Originally spun out of Stanford University, the company uses machine learning and natural language processing to mine court documents and provide predictive analytics on judges, lawyers, and parties. While not a life sciences company itself, it offers specialized modules for the pharmaceutical and medical device industries, focusing on patent litigation (ANDA/Hatch-Waxman) and product liability. The company's platform allows users to predict the behaviors and outcomes of different legal strategies by analyzing millions of pages of legal information. Lex Machina was acquired by LexisNexis in 2015 and continues to operate as a key part of their legal research suite.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lex Machina.